Holen Sie sich die Stockscreener-App
59.97
0.04%
-0.0299
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CYTK?
Forum
Prognose
Aktiensplit
Finanzdaten der Cytokinetics Inc-Aktie (CYTK)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
817.10%
17.75
|
1.936 | 66.77 | 1.579 | 0.463 |
Operating Expenses
|
16.26%
196.12
|
168.69 | 178.28 | 157.21 | 141.26 |
| Interest Income/Expense |
25.73%
14.27
|
11.35 | 11.08 | 8.868 | 8.928 |
| Benefits Costs and Expenses |
200.79
|
- | - | 162.96 | - |
| Costs And Expenses |
19.03%
200.79
|
168.69 | 178.28 | 162.96 | 141.26 |
| Operating Income/Loss |
6.96%
-178.37
|
-166.75 | -111.51 | -155.63 | -140.80 |
| Nonoperating Income/Loss |
11.92%
11.47
|
10.25 | 13.00 | 13.70 | 17.05 |
| Income/Loss From Continuing Operations Before Tax |
9,554%
-183.03
|
1.936 | -134.37 | -161.38 | 0.463 |
| Income/Loss From Continuing Operations After Tax |
40.22%
-183.03
|
-306.18 | -134.37 | -161.38 | -160.54 |
|
Net Income/Loss
|
40.22%
-183.03
|
-306.18 | -134.37 | -161.38 | -160.54 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
99.34%
0.000786
|
0.12 | 0.1195 | 0.1185 | 0.1177 |
| Diluted Average Shares |
99.34%
0.000786
|
0.12 | 0.1195 | 0.1185 | 0.1177 |
| Basic Earnings Per Share |
41.18%
-1.50
|
-2.55 | -1.12 | -1.36 | -1.36 |
| Diluted Earnings Per Share |
41.18%
-1.50
|
-2.55 | -1.12 | -1.36 | -1.36 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):